Wiley adds new titles in several categories to its lineup

Share this article:
Wiley adds new titles in several categories to its lineup
Wiley adds new titles in several categories to its lineup

Wiley's 2013 is looking like an expansive year. The publisher announced in March that it will enter 2014 with at least 66 new titles under its umbrella, 52 of which were snapped up from other publishers or were self-published.

The new titles span several categories including scientific, medical and scholarly research and education. Among the new journals are former Nature pub Obesity, which Wiley has been publishing since the first of the year. Wiley landed the title through a tendering process that began two years ago. Clinical Pharmacology in Drug Development and the Journal of Clinical Pharmacology came over from Sage; the titles are packaged as a two-for-one, with a subscription base of around 500 institutions.

The formerly self-published Journal of the Experimental Analysis of Behavior (612 institutional subscribers) and Journal of Applied Behavior Analysis (1,006 institutional subscriptions) joined up after a 2012 bidding process. Wiley's first JEAB issue went out in January, and JABA hit its Wiley milestone this month.

Wiley's acquisition mode also includes open-access titles. The company has confirmed 10 new open-access titles for 2013, including Physiological Reports and Immunity, Inflammation and Disease, and expects to add three more titles this year, which would bring its open-access titles to around 25. The pipeline isn't all rehashes: among the new-to-market titles is Stat, an “online-only rapid communication research journal.”
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?